BusinessIGC Announces Financial Results for Fiscal Year Ended March 31, 2017By Nasdaq OMXJul 14, 2017, 6:00 AM UTC
BusinessIGC Launches Phytocannabinoid Development Committee to Secure Preclinical Initiatives for IGC-501, IGC-502 and IGC-504By Nasdaq OMXFeb 13, 2017, 11:01 AM UTC
BusinessIGC Launches Phytocannabinoid Development Committee to Secure Preclinical Initiatives for IGC-501, IGC-502 and IGC-504By Nasdaq OMXFeb 13, 2017, 11:01 AM UTC
BusinessIGC Files International Applications for Cannabinoid Composition and Method PatentsBy Nasdaq OMXMar 15, 2016, 12:30 PM UTC
